{"id":14830,"date":"2018-03-28T10:01:21","date_gmt":"2018-03-28T10:01:21","guid":{"rendered":"https:\/\/www.revoscience.com\/en\/?p=14830"},"modified":"2020-05-27T06:03:08","modified_gmt":"2020-05-27T06:03:08","slug":"how-often-do-medical-problems-lead-to-bankruptcy","status":"publish","type":"post","link":"https:\/\/www.revoscience.com\/en\/how-often-do-medical-problems-lead-to-bankruptcy\/","title":{"rendered":"How often do medical problems lead to bankruptcy?"},"content":{"rendered":"

Poor health is a less common cause of bankruptcy than commonly thought, but it brings other economic woes.<\/em><\/strong><\/span><\/p>\n

\"\"
A team of researchers led by an MIT economist has found that medical expenses account for roughly 4 percent of bankruptcy filings among nonelderly adults in the U.S.<\/figcaption><\/figure>\n

CAMBRDIGE, MASS.–A team of researchers led by an MIT economist has found that medical expenses account for roughly 4 percent of bankruptcy filings among nonelderly adults in the U.S.<\/span><\/p>\n

The scholars combined medical records and financial data for hundreds of thousands of people to pinpoint the percentage of bankruptcies caused by medical costs, thus giving new empirical precision to a topic of considerable policy importance.<\/span><\/p>\n

The 4 percent figure is lower than some commonly cited estimates, but the new statistic comes with a twist: It is part of a\u00a0larger research project<\/a>\u00a0that found multiple negative economic consequences of having medical problems, including a 20 percent drop in earnings and an 11 percent drop in employment for adults between ages 50 and 59 who had been hospitalized.<\/span><\/p>\n

This combination of effects \u2014 fewer medically rooted bankruptcies but pervasive workplace troubles for people with health issues \u2014 underscores the need to understand the full range of financial challenges people face due to their medical needs, the researchers say.\u00a0<\/span><\/p>\n

\u201cIt doesn\u2019t mean there aren\u2019t really adverse economic consequences from adverse health,\u201d says MIT economist Amy Finkelstein, co-author of a new paper outlining the findings. \u201cIt just turns out they\u2019re not [strictly] about bankruptcy. They\u2019re much more about lost employment and earnings.\u201d<\/span><\/p>\n

The article, \u201cMyth and Measurement \u2014 The Case of Medical Bankruptcies,\u201d appears today in the\u00a0New England Journal of Medicine<\/em>. The co-authors are Finkelstein, who is the John and Jennie S. MacDonald Professor of Economics at MIT; Carlos Dobkin, a professor of economics at the University of California at Santa Cruz; Raymond Kluender, a PhD student in economics at MIT; and Matthew Notowidigdo, an associate professor of economics at Northwestern University.<\/span><\/p>\n

The study\u2019s main source of data consists of hospitalization records from the years 2003\u20132007 and credit reports from 2002\u20132011, from the state of California, for people over age 25. The study included about 780,000 people with health insurance and roughly 150,000 people without health insurance. That information was available to the research team only under particular conditions that preserved the anonymity of the people being studied.<\/span><\/p>\n

By examining cases where previously healthy people were hospitalized, then tracking the finances of those people in subsequent years, the researchers were able to study the issue in a way that delivers a solid link between cause and effect \u2014 namely, how often medical events themselves are the principal cause of changes in financial status.\u00a0<\/span><\/p>\n

Some of the previous research on the frequency of medically caused bankruptcies used survey data to produce estimates; one commonly cited figure is that 60 percent of bankruptcies have medical causes. However, those estimates used self-reported data about health issues, among those who filed for bankruptcy, without establishing that medical costs were the principal cause of those bankruptcies.<\/span><\/p>\n

\u201cThe approach of the prior literature was just conceptually not right,\u201d Finkelstein says.<\/span><\/p>\n

The current study found that poor health has a larger impact on the uninsured than the insured: For instance, as a related, recently published paper by the research team shows, four years after being admitted to the hospital, people with insurance owe $300 more in unpaid medical bills, on average, while people without insurance have an average increase of $6,000 in unpaid medical bills.<\/span><\/p>\n

The researchers also found that medically caused bankruptcies are minimal among the elderly \u2014 those over age 64 \u2014 who are likely to have Medicare and who tend to be retired, thus not suffering the earnings reductions that ill people in the workforce experience.<\/span><\/p>\n

\u201cWe suspect what\u2019s driving the [level of] bankruptcy we find is the fact that some people lose their job because of adverse health, and in turn that causes them to go bankrupt,\u201d Finkelstein says. \u201cThat\u2019s just not going to [apply to] the elderly, because they\u2019re not working, so they don\u2019t have the labor market risk from poor health.\u201d<\/span><\/p>\n

To be sure, Finkelstein acknowledges, the current study has some aspects that may need additional scrutiny. By focusing on examples involving hospitalization, the researchers could be missing some cases in which accumulated medical costs of other kinds drive people to bankruptcy \u2014 including medical costs incurred by children, parents, or other relatives.<\/span><\/p>\n

\u201cWe\u2019re not going to go to the mat over the idea that [the rate of medically caused bankruptcies] is always going to be 4 percent in every context and by every measurement,\u201d Finkelstein says. Still, she notes, the accurate figure is likely to be much lower than other recent estimates imply.<\/span><\/p>\n

To Finkelstein, the findings also have a clear upshot for policymakers and legislators. Grasping the full breadth of the economic consequences of poor health might affect the priorities of lawmakers, directing them to seek solutions for the lost income that many people endure after a serious medical event.<\/span><\/p>\n

\u201cFocusing on bankruptcy might lead you to think about bankruptcy protection reform,\u201d Finkelstein says, \u201cand while that may or may not be useful in its own right, if you\u2019re interested in the economic consequences of poor health, you\u2019re missing a main issue and potential policy responses \u2014 thinking about how we might want to structure sick pay and disability insurance.\u201d<\/span><\/p>\n

Some of the research data pertaining to job outcomes, covering the years 1992\u20132012 for nearly 10,000 people, was obtained from the Health and Retirement Study (HRS), a biannual U.S. national survey supported by the National Institute on Aging and the Social Security Administration, and directed by the University of Michigan.<\/span><\/p>\n

Support for the study came in part from the National Institute on Aging and the National Science Foundation.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Poor health is a less common cause of bankruptcy than commonly thought, but it brings other economic woes. CAMBRDIGE, MASS.–A team of researchers led by an MIT economist has found that medical expenses account for roughly 4 percent of bankruptcy filings among nonelderly adults in the U.S. The scholars combined medical records and financial data […]<\/p>\n","protected":false},"author":6,"featured_media":14831,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34,22,17],"tags":[],"class_list":["post-14830","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economics","category-other","category-research"],"featured_image_urls":{"full":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0-150x150.jpg",150,150,true],"medium":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0-300x200.jpg",300,200,true],"medium_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"1536x1536":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"2048x2048":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"ultp_layout_landscape_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"ultp_layout_landscape":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"ultp_layout_portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",600,400,false],"ultp_layout_square":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",600,400,false],"newspaper-x-single-post":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"newspaper-x-recent-post-big":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",540,360,false],"newspaper-x-recent-post-list-image":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",95,63,false],"web-stories-poster-portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",639,426,false],"web-stories-publisher-logo":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",96,64,false],"web-stories-thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2018\/03\/MIT-Medical-Bankruptcies_0.jpg",150,100,false]},"author_info":{"info":["Amrita Tuladhar"]},"category_info":"Economics<\/a> Other<\/a> Research<\/a>","tag_info":"Research","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/14830","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/comments?post=14830"}],"version-history":[{"count":0,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/14830\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media\/14831"}],"wp:attachment":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media?parent=14830"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/categories?post=14830"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/tags?post=14830"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}